Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFOXIRI vs FOLFIRI in Metastatic Colorectal Cancer
NCT01219920Phase 3Completed
- Sponsor
- Gruppo Oncologico Nord Ovest
- Start
- Nov 2001
- Primary completion
- Nov 2005
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin in metastatic colorectal cancer (mCRC), sponsored by Gruppo Oncologico Nord Ovest. Started Nov 2001; status: completed.
02
Drugs
oxaliplatin
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01219920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01219920.